Whereas prolonged elevation of circulating levels of PTH, as in hyperparathyroidism, increases turnover and leads to bone loss, intermittent daily PTH increases bone mass and is used as an anabolic agent in the treatment of osteoporosis (3–6). This evidence concerns the gene PTH and hyperparathyroidism.